
Ucb
(OTC) UCBJY
Ucb Financials at a Glance
Market Cap
$60.43B
Revenue (TTM)
€13.86B
Net Income (TTM)
€2.61B
EPS (TTM)
$4.59
P/E Ratio
33.87
Dividend
$0.85
Beta (Volatility)
0.47 (Low)
Dividend
$0.85
Beta (Volatility)
0.47 (Low)
Price
$158.72
Volume
12,696
Open
$157.44
Price
$158.72
Volume
12,696
Open
$157.44
Previous Close
$158.72
Daily Range
$157.07 - $160.08
52-Week Range
$89.00 - $168.76
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.85
Beta (Volatility)
0.47 (Low)
Price
$158.72
Volume
12,696
Open
$157.44
Previous Close
$158.72
Daily Range
$157.07 - $160.08
52-Week Range
$89.00 - $168.76
Estimated Earnings Date
Jul 30, 2026
UCBJY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ucb
Industry
Pharmaceuticals
Sector
Health CareEmployees
10,117
CEO
Jean-Christophe Tellier, MD
Website
www.ucb.comHeadquarters
Brussels, 1070, BE
UCBJY Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
25%
Net Income Margin
20%
Return on Equity
15%
Return on Capital
14%
Return on Assets
9%
Earnings Yield
2.95%
Dividend Yield
0.54%
Payout Ratio
16.94%
Stock Overview
Market Cap
$60.43B
Shares Outstanding
380.72M
Volume
12.70K
Avg. Volume
41.98K
Financials (TTM)
Gross Profit
€5.29B
Operating Income
€1.12B
EBITDA
€1.72B
Operating Cash Flow
€2.08B
Capital Expenditure
-€269.91M
Free Cash Flow
€1.81B
Cash & ST Invst.
€2.47B
Total Debt
€2.24B
Ucb Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€4.22B
+58.6%
Gross Profit
€3.04B
+83.6%
Gross Margin
71.91%
N/A
Market Cap
$60.43B
N/A
Market Cap/Employee
$6.68M
N/A
Employees
9,052
N/A
Net Income
€1.07B
+3259.3%
EBITDA
€1.59B
+194.1%
Quarterly Fundamentals
Total Cash
€2.47B
+167.5%
Total Debt
€2.24B
-26.1%
Accounts Receivable
€1.79B
+132.6%
Inventory
€1.50B
+45.0%
Long Term Debt
€2.18B
-27.2%
Short Term Debt
€61.97M
+47.6%
Return on Assets
8.58%
N/A
Return on Invested Capital
14.25%
N/A
Free Cash Flow
€1.38B
+344.9%
Operating Cash Flow
€1.55B
+231.1%